Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

WithSecure affirms commitment to protecting clients in Australia, New Zealand

The cyber security firm highlights the growing importance of security in the cloud era.Helsinki, Finland – November 29, 2022: Cyber threats are following businesses as they migrate to the cloud, compounding existing challenges for organizations across the globe. To help raise awareness of these challenges and the potential solutions, WithSecure ™ (formerly known as F-Secure business) is joining Finnish Prime Minister Sanna Marin and Business Finland to reach out to organizations in Australia and New Zealand. According to data from the cyber security firm,

Biomedical Bonding AB appoints Evelina Mikaelson as new CEO

Biomedical Bonding announces today that Evelina Mikaelson has been appointed new CEO effective January 1[st], 2023. This strategic appointment follows a comprehensive search process initiated after the founder and CEO Professor Michael Malkochs decision to step down as CEO as the company enters a more expansive commercial phase.Biomedical Bonding AB is establishing a new paradigm in bone fracture fixation and restoration surgery based on its technological platform Bonevolent™ - bone-like medical adhesives and composite implants. Bonevolent™ products provide surgeons with unprecedented

Noreco: Temporary injunction relating to the proposed amendments to the NOR13 bond issue – relevance for extraordinary general meeting to be held on 30 November 2022

Oslo, 29 November 2022: Reference is made to the stock exchange announcement on 8 November 2022 where Norwegian Energy Company ASA ("Noreco" or the "Company") announced summons for a written resolution with proposed amendments (“Amendments”) to the Company's outstanding USD 165,229,319 2019/2027 convertible bond loan with ISIN NO0010851520 issued by Noreco and listed on Oslo Børs ("NOR13"). The Amendments were resolved by written resolution according to the voting requirements of the NOR13 bond terms, as announced on 8 November 2022. Noreco has received a temporary injunction from the

Buy-back of shares in MTG during week 47, 2022

During the period between 21 November to 25 November 2022 Modern Times Group MTG AB (publ) (LEI code 549300E8NDODRSX29339) (“MTG”) repurchased, in total, 165,413 own class B shares (ISIN code SE0018012494) under the share repurchase program initiated by the Board of Directors to deliver shareholder value and to optimize the capital structure of the company.The share buy-backs form a part of the share repurchase program of a maximum of 4,618,818 shares for a maximum amount of SEK 400 million, which MTG announced on 25 October 2022. The share repurchase program, which runs from 27 October

Wärtsilä drives decarbonisation and lower operating costs with re-powering of inland waterway pusher vessel

Wärtsilä Corporation, Trade press release, 29 November 2022 at 10.30 AM EETThe technology group Wärtsilä will carry out the most complete re-powering project ever carried out on an inland waterway vessel. The project scope will retrofit the ‘Herkules V’, a pusher vessel owned by Hidrovias do Brasil, to achieve notably increased efficiency, reduced emissions, and lower operating costs. The order was included in Wärtsilä’s order book in the first quarter 2022. The full scope of Wärtsilä’s contract includes three Wärtsilä 20 engines, three Wärtsilä fixed pitch propellers, three gearboxes,

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 252 - 29 NOVEMBER 2022 In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 230/22 and 233/22.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Thomas France, Investor Communications Partner, tel.: 3315 0451

Green light for stem cell-based Parkinson’s study

The Swedish Medical Products Agency has approved an application from a consortium of research institutions, which includes Lund University, to initiate a clinical phase I and a phase IIa study in Parkinsons disease, STEM-PD. The aim is to investigate whether transplanted nerve cells, which form dopamine and are generated from embryonic stem cells, can replace the nerve cells that are destroyed at disease onset. Thus begins another clinical trial in this neurodegenerative chronic disease that, after 105 years after its discovery, still lacks curative treatments.Read the full article at

GoIP cuts costs by 40% with Smartoptics DCP-404 muxponder

Oslo, Norway – November 29 – Smartoptics, a leading provider of optical networking solutions, today announced that GoIP, a leading ICT and managed service provider in the APAC region, has selected Smartoptics for increased DWDM cost efficiency. The Smartoptics solution helped GoIP cut costs and decrease pricing to its customers by 40%. GoIP will also act as a distributor and support partner for Smartoptics products across a number of Asian markets.GoIP is based out of Singapore, a major global undersea cable hub. The ICT and managed service provider also has a strong presence across the

Interim report for Q3 2022: Revenue increase of 40% in Q3 and a successful DKK 8 million capital raise

Inside information Today, LED iBond International’s (LED iBond) Board of Directors approved the interim report for Q3. Martin Løbel, CEO of LED iBond international comments:“I’m delighted that LED iBond has succeeded in raising DKK 8 million in a difficult market. I’m also pleased to see that we increased our topline by 40% compared to Q3 in the previous year. This is the second quarter in a row where revenue is growing. Q3 underlines the importance of the strategic initiatives in refocusing our smart building sales activities, where Tracy has a strong edge and secondly to develop

Finns fell in love with Fazer’s Pätkis and Dumle Oat Drinks made from Finnish oats – more than a million litres of these drinks have been produced this year

Fazer has introduced beloved sweet brands also to the oat drink shelf. Fazer Dumle Oat Drink, launched a year ago, and Fazer Pätkis Oat Drink, which joined the team this autumn, have found their way into the hearts and shopping baskets of Finns. They have also been praised on social media. Made from Finnish oats at the Fazer factory in Koria, the delicious drinks are favourites of children and adults alike.In recent years, Fazer has invested a lot in oat-based products. The company has doubled the capacity of its oat mills and made investments in oat drink and snack production facilities in

Klaria submits Marketing Authorization Application for Sumatriptan Alginate Film in Europe

UPPSALA — November 29, 2022 — Klaria Pharma AB (publ) (Nasdaq Stockholm: KLAR) today announces that the Company has submitted a Marketing Authorization Application (MAA) for Sumatriptan Alginate Film for the treatment of Migraine in the European Union.  Pending positive validation, Sumatriptan Alginate Film will be subject to a regulatory assessment according to the standard timeline, which would result in approval in Q1, 2024.“Sumatriptan Alginate Film addresses an important medical need in patients with migraine.  With the submission of the MAA, we have now successfully done everything we

Esmaeilzadeh Holding AB publishes interim report for the first nine months of 2022

“The last nine months have underlined the fundamental strength of our portfolio. Despite significant external challenges, performance has been maintained, transactions have been completed and the company has diversified geographically. EHAB’s investment portfolio now consists primarily of well-established operational groups with profitable businesses in numerous sectors. It is this structure that offers protection. During the third quarter, we had a lower rate of investments than the previous two quarters, along with a greater focus on further developing the operational activities of the

Electric railway engines, artificial intelligence, machine vision and an extensive network of wood terminals are used for wood logistics at Metsä Group’s Kemi bioproduct mill

Metsä Group press release 29 November 2022An entirely new operating method has been adopted for the wood logistics of Metsä Group’s Kemi bioproduct mill. It combines electrified rail transports, the weighing and reception of wood at wood terminals, artificial intelligence, and machine vision. “The Kemi bioproduct mill receives two thirds of the wood it uses by train. Smooth rail logistics are essential to ensure that the bioproduct mill receives the volume of wood it needs,” says Hannu Alarautalahti, SVP, Production, Metsä Forest.  Metsä Group’s Kemi bioproduct mill will start up in

Viaplay’s next Danish drama series is ‘Bullshit’

· Unconventional drama set in 1980s biker subculture in Copenhagen · Alba August (‘Becoming Astrid’) and Marco Ilsø (‘Vikings’) headline all-star cast · ‘Bullshit’ produced by Nordisk Film Creative Alliance A notorious biker-gang war in 1980s Copenhagen forms the backdrop for Viaplay’s ‘Bullshit’, an unconventional coming-of-age drama headlined by some of Denmark’s biggest screen talents. Created and written by Milad Alami (‘Follow the Money’; ‘The Charmer’), Bo Hr. Hansen (‘Bamse’; ‘The Purity of Vengeance’) and Molly Malene Stensgaard (‘Aquarela’), the six-part series is based on

Nightingale Health Plc – Managers’ transactions – Leena Niemistö

Nightingale Health Plc – Managers’ transactions – 29 November 2022 9:45 a.m. (EET) ____________________________________________ Person subject to the notification requirement Name: Kaikarhenni Oy Position: Member of the Board/Deputy member (X) Legal person (1):Person Discharging Managerial Responsibilities In Issuer Name: Leena Niemistö Position: Member of the Board Issuer: Nightingale Health Plc LEI: 743700WUIPC24LVMLO66   Notification type: INITIAL NOTIFICATION Reference number: 21425/4/5 ____________________________________________ Transaction

Nightingale Health Plc – Managers’ transactions – Leena Niemistö

Nightingale Health Plc – Managers’ transactions – 29 November 2022 9:45 a.m. (EET)  ____________________________________________ Person subject to the notification requirement Name: Niemistö, Leena Position: Member of the Board/Deputy member Issuer: Nightingale Health Plc LEI: 743700WUIPC24LVMLO66   Notification type: INITIAL NOTIFICATION Reference number: 21421/4/4 ____________________________________________ Transaction date: 2022-11-25 Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME) Instrument type: SHARE ISIN: FI4000490875 Nature of the

Mainstream Renewable Power and Maple Power to Partner for Upcoming Celtic Sea Floating Offshore Wind Tender

Mainstream Renewable Power (“Mainstream”), the global pure-play renewable energy company majority-owned by Aker Horizons, and Maple Power, a leading European offshore wind developer, are jointly exploring the upcoming Celtic Sea Floating Offshore Wind Tender in the UK, which will be launched in 2023.The Crown Estate is advancing the Celtic Sea seabed leasing tender for floating wind, which is anticipated to deliver a total of 4 GW of renewable energy by 2035. The region has the potential to generate up to an additional 20 GW by 2045, helping to support the UK’s energy transition and future

GARO to launch next generation smart wall boxes for destination charging – GARO Entity

Safety and security were the focal points of the development of the new platform, GARO Entity. The new products that are now being launched to the European market comprise a complete offering of wall boxes and services for single-family homes, apartment blocks, commercial properties and public environments in cities and the wider community. The products have been stringently tested to ensure that they withstand the harsh Nordic climate and all products are approved in accordance with prevailing European electricity and safety standards.“With GARO Entity, we can offer the market’s most

Crown Energy AB: Operational Update and Correction for previous Q1 and Q2 reports from Crown Energy

INSIDE INFORMATION: This is an update on the recent developments in Crown Energy’s operations. The update includes a significant correction for Q1 and Q2 report, where the financial costs for the group were reported 94 MSEK too high, due to revaluation of a non-monetary liability. Also, Crown Energy would like to inform that it will not pursue the negotiation of Manja Licence in Block 3108 in Madagascar, which will affect Crown Energy’s financial statements in Q4 2022.   CORRECTION FOR FINANCIAL REPORTS FOR Q1 AND Q2   Crown Energy has identified a mistake in Q1 and Q2 reports.

BioStock: Miris reports Q3 sales growth

Medtech company Miris reports sales growth for Q3, continuing the positive trend from the first half of the year. Sales increased by as much as 133 per cent and the company is well on its way to profitability as the net loss was halved compared to the same quarter 2021. Miris’ CEO Camilla Myhre Sandberg commented on the report and talked about the prospects for the company’s market-approved instruments for analysing breast milk.Read the interview with Miris' CEO Camilla Myhre Sandberg at biostock.se: https://www.biostock.se/en/2022/11/miris-reports-q3-sales-growth/ This is a press

Change in Relais Group Plc’s dividend policy

Relais Group PlcStock Exchange Release 29 November 2022 9.15 a.m. EET Relais Group Plc's Board of Directors has today, on 29 November 2022, decided on a change to the company’s dividend policy, taking into account the impact caused by the transition to IFRS reporting in defining the dividend basis. The amended dividend policy is as follows: Relais’ dividend policy is to target annual dividends that exceed 30 percent of the average comparable earnings per share of the group, over a business cycle. In proposing the dividend, the group’s equity, acquisition opportunities and financing

There are no items matching the current filter
There are no more items matching the current filter
Back to top